https://www.selleckchem.com/products/OSI-906.html
) or THC/CBD (1.22 cm [95% CI, -0.29 to 2.72]; P = .2 conditions, relative to placebo. Out of 188 test drives, 16 (8.5%) were terminated due to safety concerns. In a crossover clinical trial that assessed driving performance during on-road driving tests, the SDLP following vaporized THC-dominant and THC/CBD-equivalent cannabis compared with placebo was significantly greater at 40 to 100 minutes but not 240 to 300 minutes after vaporization; there were no significant differences between CBD-dominant cannabis and placebo. However, the e
Like
Comment
Share
